Health
Preliminary study finds blood marker may help diagnose CTE in living patients
Researchers at Washington University in St Louis reported a blood protein fragment elevated in advanced CTE, but the test cannot yet reliably detect early-stage disease.
The short version
- Washington University researchers identified a blood protein fragment, eMTBR-tau243, that is elevated in advanced chronic traumatic encephalopathy (CTE).[The Guardian]
- CTE can currently be diagnosed only after death through brain tissue examination, so a blood test could be a step toward diagnosis in living patients.[The Guardian]
- In 11 people with autopsy-confirmed CTE, the marker distinguished advanced disease from healthy people but could not reliably detect early-stage CTE.[The Guardian]
- A neuropathologist not involved in the research called the finding very preliminary, and the test has not yet been validated for diagnosing CTE.[Associated Press · The Guardian]
Key facts
- Scientists at Washington University School of Medicine in St Louis identified a blood protein fragment, eMTBR-tau243, that is elevated in advanced CTE.[The Guardian]
- CTE can currently be diagnosed only after death by examining brain tissue.[The Guardian]
- In tests on blood from 11 people whose CTE was confirmed at autopsy, eMTBR-tau243 levels were higher than in healthy people and rose with disease severity.[The Guardian]
- The test could distinguish advanced CTE from healthy people with high accuracy but could not reliably identify early-stage CTE.[The Guardian]
- The test has not yet been validated for diagnosing CTE.[The Guardian]
- Neuropathologist Rudolph Castellani of Northwestern University, who was not involved in the research, called the finding very preliminary and said larger studies are needed to see if there is a real connection.[Associated Press]
What remains uncertain
- It is unknown whether the marker can reliably detect early-stage CTE, and the accuracy findings rest on a small sample of 11 people.[Associated Press · The Guardian]
- Larger validation studies are needed before the finding can be treated as a diagnostic tool; an outside expert called it very preliminary.[Associated Press]
Sources
Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.
- Scientists find blood biomarker that opens door to CTE diagnosis in living patientsThe Guardian - US
- Preliminary study finds a clue in the quest to help diagnose CTE in the livingAssociated Press · Wire: associated-press